febuxostat has been researched along with Arteriosclerosis, Coronary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breton, E; Czarny, M; Gerstenblith, G; Hays, AG; Iantorno, M; Lai, S; Palmer, RN; Schär, M; Weiss, RG; Whelton, A | 1 |
1 trial(s) available for febuxostat and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial.
Topics: Coronary Artery Disease; Coronary Vessels; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Endothelium, Vascular; Febuxostat; Female; Gout Suppressants; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxidative Stress; Treatment Outcome; Xanthine Oxidase | 2018 |